Why the study?
The role of ROR2, a Wnt/PCP-specific tyrosine kinase receptor crucial for cardiovascular development, in pulmonary arterial hypertension and pulmonary endothelial homeostasis was unclear.
Population
Endothelial-specific ROR2 knockout and wild-type mice, and PMVECs from healthy and PAH lungs
Comparison
ROR2 ECKO vs wild-type under normoxia and chronic hypoxia, and PMVECs transfected with ROR2 siRNA/constructs
Design
Preclinical animal and cellular experimental study
Authors
Loading...
ROR2 may be a therapeutic target in PAH; leaves open translation from murine hypoxia models to human disease.
ROR2 regulates pulmonary angiogenesis by maintaining endothelial barrier integrity, and its loss exacerbates pulmonary hypertension, highlighting ROR2 restoration as a potential therapeutic approach for PAH.
Mitra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: